Third Rock enters $2B partnership with AI-focused Chinese biotech
Third Rock Ventures is betting up to $2.16 billion on a little-known Chinese biotech’s AI platform. Funnel Biosciences describes itself as an AI-driven biologics company. Under a research collaboration announced Friday ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.